A recurrent gain of chromosome arm 3q in primary squamous carcinoma of the vagina

被引:17
作者
Habermann, JK
Hellman, K
Freitag, S
Heselmeyer-Haddad, K
Hellström, AC
Shah, K
Auer, G
Ried, T
机构
[1] NCI, Genet Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] Karolinska Inst, Ctr Canc, Stockholm, Sweden
[3] Karolinska Hosp, Radiumhemmet, Dept Gynecol Oncol, S-10401 Stockholm, Sweden
[4] Univ Hosp Schleswig Holstein, Inst Med Informat & Stat, Kiel, Germany
[5] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA
关键词
D O I
10.1016/S0165-4608(03)00245-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary carcinomas of the vagina are rare tumors, accounting for 2%-3% of all gynecologic malignancies. Only a few karyotypes based on chromosome banding techniques have been reported. We have, therefore, used comparative genomic hybridization to establish a pattern of genomic imbalances in vaginal squamous cell carcinomas. Analysis of 16 formalin-fixed and paraffin-embedded tumors revealed that 70% of vaginal carcinomas carry relative copy number increases that map to chromosome arm 3q. Other recurring gains were observed on chromosome arms 5p and 19p. Chromosomal losses were infrequent. Most tumors were aneuploid, as measured by image cytometry on Feulgen-stained tissue sections. The cytogenetic data were related to the presence of human papillomavirus genomes, expression of laminin-5 as a marker for invasiveness, and expression levels of markers for proliferative activity and mutated TP53. All relevant clinical data were recorded. The results suggest that vaginal carcinomas are defined by a specific distribution of chromosomal aneuploidies and that the pattern of genomic imbalances is strikingly similar to that observed in squamous cell carcinomas of the uterine cervix. Age at diagnosis (P = 0.031), tumor size (P = 0.025), and increased laminin-5 expression (P = 0.006) have a significant influence on the survival time. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 37 条
[1]  
AUER GU, 1994, VIRCHOWS ARCH, V424, P343
[2]  
BENEDET JL, 1983, OBSTET GYNECOL, V62, P715
[3]   CASE CONTROL STUDY OF INSITU AND INVASIVE-CARCINOMA OF THE VAGINA [J].
BRINTON, LA ;
NASCA, PC ;
MALLIN, K ;
SCHAIRER, C ;
ROSENTHAL, J ;
ROTHENBERG, R ;
YORDAN, E ;
RICHART, RM .
GYNECOLOGIC ONCOLOGY, 1990, 38 (01) :49-54
[4]   NEOPLASMS OF THE VAGINA FOLLOWING CERVICAL-CARCINOMA [J].
CHOO, YC ;
ANDERSON, DG .
GYNECOLOGIC ONCOLOGY, 1982, 14 (01) :125-132
[5]  
Daling J R, 1992, IARC Sci Publ, P223
[6]  
DEVITA VT, 2001, CANC PRINCIPLES PRAC, V1
[7]  
Goodman A, 1998, Surg Oncol Clin N Am, V7, P347
[8]  
Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
[9]   Ulcerative colitis and colorectal carcinoma -: DNA-profile, laminin-5 γ2 chain and cyclin A expression as early markers for risk assessment [J].
Habermann, J ;
Lenander, C ;
Roblick, UJ ;
Krüger, S ;
Ludwig, D ;
Alaiya, A ;
Freitag, S ;
Dümbgen, L ;
Bruch, HP ;
Stange, E ;
Salo, S ;
Tryggvason, K ;
Auer, G ;
Schimmelpenning, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (07) :751-758
[10]  
HENSON D, 1977, AM J OBSTET GYNECOL, V129, P525